Abbott has expanded its manufacturing capabilities at its multi-product potent facility with the recent installment of a new roller compactor. The new granulation equipment for solid dose potent formulations, aims to provide customers with the greater flexibility and efficiency to advance their drug products. 
 
Abbott’s potent API and drug product contract manufacturing facility, located in Sligo, Ireland, also offers wet granulation, compression, coating and tableting processes for potent compounds.